Pancreatic neuroendocrine tumors (pNETs) are a heterogeneous group of tumors with
complicated treatment options that depend on pathological grading, clinical staging, and …

Gastroenteropancreatic neuroendocrine neoplasia (GEPNEN) comprises clinically as well
as prognostically diverse tumour entities often diagnosed at late stage. Current classification …

Clear cell renal cell carcinoma (ccRCC) is the seventh most frequently diagnosed tumor in
adults in Europe and represents approximately 2.5% of cancer deaths. The molecular …

According to the 2019 WHO pathology grading system, high-grade gastroenteropancreatic
neuroendocrine neoplasms (GEP-NENs) can be divided into well differentiated …

Simple Summary Neuroendocrine neoplasms are highly heterogeneous tumors in terms of
primary origin, molecular landscape, clinical presentation and behavior. To date, several …

Gallium-68 was applied for positron emission tomography (PET) imaging already in the
early beginnings of PET imaging. Today, with the introduction of PSMA-targeting tracers (eg …

Oncolytic viruses have made a significant inroad in cancer drug development. Numerous
clinical trials are currently investigating oncolytic viruses both as single agents or in …

Well-differentiated lung neuroendocrine tumours (Lu-NETs), classified as typical (TC) and
atypical (AC) carcinoids, represent 30% of NETs. Angiogenesis plays an essential role in …

Introduction: Pancreatic neuroendocrine tumors (panNETs) represent a rare group of
malignancies. For decades, chemotherapy, somatostatin analogs and interferon …

Neuroendocrine tumors (NETs) represent a group of biologically and clinically
heterogeneous neoplasms arising from the diffuse neuroendocrine system. Although NETs …